Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Understand in 2 minutes

Understand in 2 minutes: ataxias

Comprendre en 2 minutes : les ataxies
Retour à la recherche

Ataxia is a rare neurological disease that affects the coordination of movement. They originate in a malfunction of the cerebellum, a key area of the brain at the base and back of the skull. Responsible for the coordination, balance and precision of gestures, the cerebellum plays a fundamental role in our ability to perform voluntary movements. When this area is damaged or altered, a highly characteristic set of symptoms develops, called cerebellar syndrome.
 

What is cerebellar ataxia?

Cerebellar ataxia manifests itself in a global disturbance of voluntary movements. This means that the simplest everyday actions of walking, talking and grasping become awkward, unstable or imprecise.

Disorders vary depending on the area of the body:

  • In the lower limbs, people have difficulty standing or walking. Walking becomes unstable, often enlarged, as if the patient were trying to regain his balance by spreading his feet apart.
  • At arm level, gestures become less precise and less fluid.
  • Speech can become explosive, hackneyed, difficult to understand — a typical sign of cerebellar syndrome.
  • Other functions are also affected, such as swallowing or eye movements, which the physician may observe during the clinical examination.

These symptoms are the direct result of the cerebellum, an organ that specializes in fine coordination and permanent adjustment of our movements.

What causes ataxia?

The causes of ataxia are many and varied. There are three main types:

Acute causes

They occur abruptly, often as a result of a vascular or traumatic event. This is the case, for example, in a cerebellar haemorrhage, which causes a sudden attack on the cerebellum with immediate symptoms.

Rapidly Progressive Causes

Here, symptoms begin over a few weeks or months. A cerebellum tumour may be responsible, progressively disrupting the structure and function of this area of the brain.

Chronic causes

These are the most complex forms. They settle slowly and may have:

  • a genetic origin, as in Friedreich’s ataxia,
  • or are related to developmental disorders, present from birth (called congenital ataxia).

These progressive diseases can remain for a long time without a cure, which makes their management particularly difficult.

How to diagnose ataxia?

Diagnosis is based on observation of clinical symptoms — particularly disturbances of balance, walking, co-ordination, speech or swallowing. The doctor can also detect abnormalities in eye movements, reliable indicators of cerebellar dysfunction.

Brain imaging (such as MRI) and genetic testing may then be prescribed to identify the exact cause of the ataxia.

What treatments for ataxia?

Treatment depends primarily on the cause. In the case of a tumour or hematoma, surgical management may be considered to remove or drain the lesion.

But in many cases, including genetic or degenerative forms, there is still no cure. Management is then based on multidisciplinary support designed to slow the progress of the disease and improve the quality of life:

  • Kinesiotherapy, to work balance and overall motor skills,
  • Orthophonics, to improve speech and swallowing,
  • Occupational therapy, to maintain autonomy in everyday activities.

Promising research advances

At the Brain Institute, researchers are actively working on the genetic forms of ataxia, which vary greatly in their manifestations and origins. The goal is twofold: to understand the cellular and molecular mechanisms that cause these diseases, and to develop new targeted treatments.

Progress has already been made. This is particularly the case for Friedreich’s ataxia, for which treatment is now available at an early stage. This drug, which is still being evaluated, is a major hope for patients and their families.

Ataxia: a major challenge for medical research

Ataxia is still largely unknown to the general public. Yet they affect thousands of people in France and around the world, often from childhood and adolescence. Their impact on daily life is considerable, and treatment is still too limited.

That’s why the work at the Brain Institute is so important. By identifying the precise causes of different forms of ataxia, researchers are paving the way for more effective, individualized, and patient-specific treatment approaches.

In the meantime, early diagnosis and multidisciplinary management remain the best weapons for limiting the development of these diseases and preserving, as far as possible, patients’ autonomy.

Neurone

Ataxias

Ataxias (a term for a group of disorders, from the Greek ‘lack of order’), also known as cerebellar syndromes, are a group of neurodegenerative pathologies of the cerebellum and/or brain stem that present as a lack of voluntary coordination of muscle...

Read more

News that might interest you

Une poignée de main
Paris Brain Institute announces a new research collaboration with Pfizer Inc.
Paris Brain Institute announces a new research collaboration with Pfizer Inc. aimed at advancing the understanding of rare neurodegenerative diseases
05.16.2022 Institutional
huntington
A gene involved in Huntington’s disease progression
Huntington’s disease, which affects about 6 000 individuals in France, is characterized by the progressive outbreak of motor, behavioral and cognitive disorders. Researchers from Alexis Brice’s team have participated in a collaborative project aiming...
12.19.2016 Research, science & health
image
Hereditary spastic paraplegia and ALS: similarities in nervous system lesions
Hereditary spastic paraplegias are a heterogeneous group of pathologies and share clinical similarities with other neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS).
04.01.2016 Research, science & health
cervelet
Spinocerebellar ataxias: a widely underestimated diversity
Spinocerebellar ataxias are a very heterogeneous group of inherited diseases associated with degeneration of the cerebellum – a region at the back of the skull that plays an essential role in motor control. Patients have gait and balance disorders...
06.21.2023 Research, science & health
cerveau
Spinocerebellar ataxia type 2: a therapeutic trial opens new avenues
A clinical trial conducted by Prof. Alexandra Durr's team (Sorbonne University.AP-HP) at the Paris Brain Institute and the Pitié-Salpêtrière Hospital AP-HP shows that despite the hopes raised in recent years, riluzole does not improve the clinical or...
01.19.2022 Research, science & health
image
Huntington's disease: brain abnormalities detectable as early as the embryonic stage
Huntington's disease is a genetic neurological disorder that generally appears in adulthood. Teams of researchers and clinicians at the Grenoble Institute of Neuroscience (Inserm/Grenoble Alpes University) and the Brain Institute (Inserm/Sorbonne...
07.17.2020 Research, science & health
See all our news